Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 2,011 | 2,474 | 1,968 | 2,524 | 699 |
| Operating Income | -2,011 | -2,474 | -1,968 | -2,524 | -699 |
| Interest Expense | 0 | 0 | 0 | 4 | 8 |
| Pre-tax Income | -2,011 | -2,474 | -1,968 | -2,527 | -707 |
| Net Income Continuous | -2,011 | -2,474 | -1,968 | -2,527 | -707 |
| Net Income | $-2,011 | $-2,474 | $-1,968 | $-2,527 | $-707 |
| EPS Basic Total Ops | -10,805.40 | -13,506.75 | -10,805.40 | -16,208.10 | -4,502.25 |
| EPS Basic Continuous Ops | -10,985.58 | -13,541.08 | -10,773.28 | -16,448.41 | -4,687.69 |
| EPS Diluted Total Ops | -10,805.40 | -13,506.75 | -10,805.40 | -16,208.10 | -4,502.25 |
| EPS Diluted Continuous Ops | -10,985.58 | -13,541.08 | -10,773.28 | -16,448.41 | -4,687.69 |
| EBITDA(a) | $-2,008 | $-2,471 | $-1,966 | $-2,523 | $-698 |